{"id":109792,"date":"2021-03-17T15:43:16","date_gmt":"2021-03-17T15:43:16","guid":{"rendered":"https:\/\/fin2me.com\/?p=109792"},"modified":"2021-03-17T15:43:16","modified_gmt":"2021-03-17T15:43:16","slug":"benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/","title":{"rendered":"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO"},"content":{"rendered":"

GENEVA (Reuters) – A World Health Organization (WHO) vaccine safety panel said on Wednesday that it considers that the benefits of the AstraZeneca COVID-19 vaccine outweigh its risks and recommends that vaccinations continue.<\/p>

FILE PHOTO: AstraZeneca logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS\/Dado Ruvic\/Illustration<\/figcaption>

The WHO listed AstraZeneca and Oxford University\u2019s vaccine for emergency use last month, widening access to the relatively inexpensive shot in the developing world.<\/p>\n

More than a dozen European countries have suspended use of the vaccine this week amid concerns.<\/p>\n

The European Medicines Agency (EMA) has said it was investigating reports of 30 cases of unusual blood disorders out of 5 million recipients of the AstraZeneca vaccine. In total, 45 million COVID shots have been delivered across the region.<\/p>\n

The EU regulator will release its findings on Thursday but its head, Emer Cooke, said she saw no reason to change its recommendation of AstraZeneca – one of four vaccines that it has approved for use.<\/p>\n

The WHO said its Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data for the AstraZeneca vaccine.<\/p>\n

\u201cOnce that review is completed, WHO will immediately communicate the findings to the public,\u201d WHO said in its statement a day after its experts held a closed-door meeting.<\/p>\n

\u201cAt this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue,\u201d it added.<\/p>\n

Kate O\u2019Brien, director of WHO\u2019s Department of Immunization, Vaccines and Biologicals, said that its vaccine safety panel was assessing whether adverse events such as blood clots were actually related to vaccination.<\/p>\n

\u201cWe should not over-interpret these specific numbers that come out of trials. They are highly effective vaccines, they are life-saving vaccines, they are safe vaccines and we should get on with deploying them,\u201d O\u2019Brien told a news conference.<\/p>\n

\u201cSo anybody who is offered vaccine should take whatever is being offered by the programme and ensure that the vaccines that are being produced, are used to their maximum benefit,\u201d she said.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

GENEVA (Reuters) – A World Health Organization (WHO) vaccine safety panel said on Wednesday that it considers that the benefits of the AstraZeneca COVID-19 vaccine […]<\/p>\n","protected":false},"author":3,"featured_media":109791,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nBenefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO - Fin2me\" \/>\n<meta property=\"og:description\" content=\"GENEVA (Reuters) – A World Health Organization (WHO) vaccine safety panel said on Wednesday that it considers that the benefits of the AstraZeneca COVID-19 vaccine [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-17T15:43:16+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/03\/cnewsfotor155.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/\",\"url\":\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/\",\"name\":\"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-03-17T15:43:16+00:00\",\"dateModified\":\"2021-03-17T15:43:16+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/","og_locale":"en_US","og_type":"article","og_title":"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO - Fin2me","og_description":"GENEVA (Reuters) – A World Health Organization (WHO) vaccine safety panel said on Wednesday that it considers that the benefits of the AstraZeneca COVID-19 vaccine [...]","og_url":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/","og_site_name":"Fin2me","article_published_time":"2021-03-17T15:43:16+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/03\/cnewsfotor155.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/","url":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/","name":"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-03-17T15:43:16+00:00","dateModified":"2021-03-17T15:43:16+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/benefits-outweigh-the-risks-of-astrazeneca-covid-shot-as-review-continues-who\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"Benefits outweigh the risks of AstraZeneca COVID shot as review continues: WHO"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/109792"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=109792"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/109792\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/109791"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=109792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=109792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=109792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}